Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03976050 |
| Title | Phase I Study of HL-085 in Patients With Advanced Solid Tumors |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Shanghai Kechow Pharma, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Livestrong Cancer Institute, Dell Medical School, The University of Texas at Austin | Austin | Texas | 78712 | United States | Details | |
| Next Oncology | San Antonio | Texas | 78229 | United States | Details |